News Related to Olix Pharmaceuticals

Related coverage linked through entity extraction aliases.

Galux raises $29 million and partners with OliX on AI-based siRNA delivery

Apr 20, 2026

Galux completed a $29 million Series B financing and entered an MOU with OliX Pharmaceuticals to jointly develop a next-generation AI-based siRNA delivery platform. The funding will support GaluxDesign, R&D expansion and preclinical validation.

New Hair Loss Drugs Target Growth Pathways, Avoid Hormone Suppression Side Effects

Mar 10, 2026

Pharmaceutical companies are developing innovative hair loss treatments that directly activate hair growth pathways rather than suppressing male hormones, with several candidates entering clinical trials and promising enhanced safety profiles.